Evidence map›Paper›PMID 30984543›Full record

ArticleFEBS open bio2019

Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.

Beichen Ding, Libin Yan, Yucong Zhang, Zhize Wang, Yangjun Zhang, Ding Xia, Zhangqun Ye, Hua Xu

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Epigenetic and Immunological Features of Bladder Cancer.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Mutational Landscape of Bladder Cancer in Mexican Patients:International journal of molecular sciences · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Multifaceted Role of PRDM Proteins in Human Cancer.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Beichen DingDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Libin YanDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Yucong ZhangDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Zhize WangDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Yangjun ZhangDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Ding XiaDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Zhangqun YeDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Hua XuDepartment of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Huazhong University of Science and Technology · CNHubei Provincial Women and Children's Hospital · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone lysine methyltransferases (HMT) comprise a subclass of epigenetic regulators; dysregulation of these enzymes affects gene expression, which may lead to tumorigenesis. Here, we performed an integrated analysis of 50 HMTs in bladder cancer and found intrinsic links between copy number alterations, mutations, gene expression levels, and clinical outcomes. Through integrative analysis, we identified six HMT genes (

Indexed as

DNA Copy Number VariationsGene ExpressionMutation RateDNA-Binding ProteinsHumansNeoplasm ProteinsUrinary Bladder NeoplasmsDNA-Binding ProteinsKMT2D protein, humanNeoplasm Proteinsbladder cancercopy numberhistone lysine methyltransferaseKMT2Dmutations

Identifiers

PMID30984543
PMCPMC6443872
OpenAlexW2912145600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.